Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplastic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Early research (Phase 1)Study completedNCT00369252
What this trial is testing

Phase I Study of Nimotuzumab in Solid Tumours

Who this might be right for
Advanced and/or Metastatic Solid Tumours
YM BioSciences 18
Large-scale testing (Phase 3)Study completedNCT00905047
What this trial is testing

Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Oscar Lambret 89
Not applicableStudy completedNCT02884947
What this trial is testing

Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI

Who this might be right for
Brain Neoplasms
University College, London 31
Early research (Phase 1)Study completedNCT03762447
What this trial is testing

A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 138
Testing effectiveness (Phase 2)Looking for participantsNCT05631249
What this trial is testing

Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C

Who this might be right for
KRAS P.G12CNon Small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 40
Testing effectiveness (Phase 2)Looking for participantsNCT07463248
What this trial is testing

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Wang Xin 64
Testing effectiveness (Phase 2)Study completedNCT01969578
What this trial is testing

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

Who this might be right for
Salivary Gland Cancer
European Organisation for Research and Treatment of Cancer - EORTC 149
Testing effectiveness (Phase 2)Study completedNCT00128843
What this trial is testing

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 103
Not applicableEnded earlyNCT05244915
What this trial is testing

A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer

Who this might be right for
Cancer
University of Rochester 73
Testing effectiveness (Phase 2)Study completedNCT00035087
What this trial is testing

EPO906 Therapy in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsColonic Neoplasms
Novartis Pharmaceuticals 62
Early research (Phase 1)Study completedNCT00072332
What this trial is testing

Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT05212987
What this trial is testing

Study of FCN-098 in Patients With Advanced Solid Tumor

Who this might be right for
Solid Tumor
Fochon Pharmaceuticals, Ltd. 43
Not applicableUnknownNCT03596593
What this trial is testing

Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumor
Peking University 8,000
Early research (Phase 1)Not Yet RecruitingNCT05940116
What this trial is testing

A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerSolid Tumor
Hansoh BioMedical R&D Company 322
Large-scale testing (Phase 3)Study completedNCT01906216
What this trial is testing

Sorafenib Chemoembolization Evaluation Controlled Trial

Who this might be right for
Hepatocellular Carcinoma
Air Force Military Medical University, China 199
Testing effectiveness (Phase 2)WithdrawnNCT04430933
What this trial is testing

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Small Cell Lung Cancer
NextCure, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04675333
What this trial is testing

Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
ALX Oncology Inc. 172
Post-approval studies (Phase 4)Study completedNCT01199198
What this trial is testing

Tolvaptan in Hyponatremic Cancer Patients

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 52
Not applicableStudy completedNCT06199232
What this trial is testing

Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Who this might be right for
Liver Metastasis Colon CancerctDNA GenotypeMSS+1 more
Peking University 47
Next Page